Splenic Function After Spleen-Preserving Distal Pancreatectomy With Excision of Splenic Artery and Vein
NCT00778362 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2008-10-23
Summary
The spleen may be removed due to benign hematologic disorders, such as idiopathic thrombocytopenic purpura and hereditary spherocytosis, or malignancies, such as lymphomas and leukemias. Splenectomy may also be performed due to splenic traumas or in association of some surgical procedures, when combined splenectomy will make the operations easier. The most well known procedure is distal pancreatectomy combined with splenectomy.
In this research, there are two main goals. Firstly, establish the data about the incidence of overwhelming postsplenectomy infection (OPSI) in our country. Currently, the western data of the incidence, morbidity rate and mortality rate of OPSI is well established and vaccination along with prophylactic antibiotics is strongly recommended. Since the incidence of OPSI in our country isn't clear, most (\>95%) splenectomized patients in our hospital (National Taiwan University Hospital) did not have vaccination or prophylactic antibiotics. We'll try to determine the incidence of OPSI by reviewing of our hospital charts and by structured interviews with patients.
The spleen is a phagocytic filter. So asplenic patients have higher risks of getting infection and some spleen-preserving procedures are proposed. In our initial experiences, distal pancreatectomy with splenic artery and vein divided could be safely performed and greatly increased the possibility of preservation of spleen. However, when the spleen was preserved with dividing the splenic artery and vein, the blood supply to the spleen will be shifted from splenic artery to short gastric artery. Although a substantial immunologic advantage exists if splenic tissue remains, this may not offer sufficient protection from encapsulated bacteria if splenic arterial blood flow is reduced because experimental animal studies have demonstrated that an intact splenic arterial system is necessary for optimal control of infection. Thus, although the spleen is preserved in above mentioned procedure, the function of the preserved spleen is questionable and has never been studied of. Our second object is to determine the splenic function after after spleen-preserving distal pancreatectomy with excision of splenic artery and vein by comparison of abdominal computed tomography and immunological function of patients before and after operation. Besides, we'll designed an animal experiment to examine the rate of pneumococcal clearance by the spleen and to determine the relationship between splenic blood flow and splenic tissue mass in bacterial clearance from the blood when the splenic vessels were divided.
Conditions
- Overwhelming Post-Splenectomy Infection
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Yu-Wen Tien, MD · National Taiwan University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2008-10-31
- Completion
- 2012-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
RF-assisted Splenic Preservation VS Conventional Treatment of Blunt Splenic Injury.
NCT03890328 ·Status: COMPLETED ·Phase: NA
-
Benefit of Prophylactic Embolization of the Splenic Salvage
NCT02021396 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Splenectomy in Isolated High Grades Splenic Injuries
NCT04329845 ·Status: COMPLETED ·Phase: NA
-
Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery
NCT01606865 ·Status: COMPLETED
-
Splenic Embolisation Decisions
NCT06334263 ·Status: RECRUITING
-
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
NCT02277379 ·Status: COMPLETED
-
Blood Salvage From Liver Donors: a Feasibility Pilot Study
NCT05835882 ·Status: COMPLETED ·Phase: NA
-
Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection
NCT07125612 ·Status: COMPLETED
-
Kinetics of D-Dimers After Abdominal Surgery
NCT00450528 ·Status: COMPLETED
-
Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery
NCT01468597 ·Status: COMPLETED
-
Traumatic Injury of Spleen:Laparoscopic Splenectomy Vs Splenic Artery Embolization
NCT07274007 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Major Bleeding Risk Following Hepatectomy
NCT04748081 ·Status: COMPLETED
-
Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery
NCT00778492 ·Status: UNKNOWN
-
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation
NCT01711957 ·Status: UNKNOWN
-
Blood Coagulation Profile After Liver Resection.
NCT05824013 ·Status: COMPLETED
-
Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)
NCT03231202 ·Status: UNKNOWN ·Phase: NA
-
Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease
NCT02316119 ·Status: COMPLETED
-
High Yield Intraoperative, Autologous Platelet Apheresis
NCT01819246 ·Status: COMPLETED ·Phase: NA
-
Platelet Function After Cardiac Surgery.
NCT06405516 ·Status: RECRUITING ·Phase: NA
-
Platelets as Regulators of Inflammation in Cardiac Surgery
NCT02568410 ·Status: COMPLETED
-
The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery
NCT01728636 ·Status: COMPLETED ·Phase: PHASE2
-
Transfusion Requirements in Surgical Oncologic Patient
NCT01502215 ·Status: COMPLETED ·Phase: PHASE3
-
Association Between Perioperative Platelet Function and Major Adverse Perioperative Events
NCT00901030 ·Status: COMPLETED
-
Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery
NCT06509256 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
NCT06023212 ·Status: RECRUITING ·Phase: PHASE1/PHASE2